Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial

Mitsuaki Sawano, Bornali Bhattacharjee, César Caraballo, Rohan Khera, Shu‐Xia Li, Jeph Herrin, Dany Christian, Andreas Coppi, Frederick Warner, Julie Holub, Yashira Henriquez, M. A. Johnson, T. Goddard, Erica Rocco, Amy Hummel, Mohammad AL Mouslmani, William Brenham Hooper, David Putrino, Kevin D Carr, Lawrence Charnas, Magdia De Jesus, Dale Nepert, Paula Abreu, Frank W Ziegler, John A. Spertus, Akiko Iwasaki, Harlan M. Krumholz